These trials completed more than 12 months ago and should have reported results. Some have, some have not.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
|Status||Trial ID||Title||Completion date||Category|
|Ongoing||2006-005071-17||Preliminary efficacy of OphenaTM (ospemifene) in the treatment of vasomotor symptoms associated with the menopause: a 6-week, randomized, double-blind, placebo-controlled, parallel-group study||not-yet-due|
|Not reported||2007-002372-33||Efficacy and Safety of Ospemifene in the Treatment of Vulvar and Vaginal Atrophy (VVA) in Postmenopausal Women: A Phase II dose ranging, 12-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel...||2008-01-11||due-trials|
|Listed as ongoing, but also has a completion date||2007-002939-90||Efficacy and long-term safety of Ospemifene in the treatment of vulvar and vaginal atrophy (VVA) in postmenopausal women: A 52-week, randomized, double-blind, placebo-controlled, parallel-group study ...||2009-06-26||bad-data|